Review Of Self-Management: Economic Theory And Yugoslav Practice By S. Estrin And The Effects Of Economic Reform In Yugoslavia: Investment And Trade Policy By J. P. Burkett [PDF]
Pryor, Frederic L.
core +2 more sources
Sex Representation in US Stroke Clinical Trials: A Decade of Trends and Challenges
ABSTRACT Objective Stroke remains a major cause of disability and mortality in the US, with significant sex‐based disparities, and females remain underrepresented in stroke clinical trials. We aimed to examine sex representation in US‐based stroke clinical trials, identify trial characteristics associated with higher female enrollment (≥ 50%), and ...
Chaitali Dagli +5 more
wiley +1 more source
Novel fat suppression technique for ultrashort echo time MRI using single-point Dixon phase modeling. [PDF]
Newbury N +10 more
europepmc +1 more source
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane +43 more
wiley +1 more source
The 10th anniversary: Journal of Intensive Care. [PDF]
Morisaki H.
europepmc +1 more source
International Research Collaboration; Just Nice to Have or Necessary? [PDF]
Müller, Marion
core +2 more sources
Von Economo Neuron Loss in Frontotemporal Dementia: A Meta‐Analysis of Neuropathological Studies
ABSTRACT Von Economo neurons (VENs) have been reported to be vulnerable to neurodegeneration in frontotemporal dementia (FTD), particularly the behavioral variant (bvFTD), but these findings have not been systematically assessed across independent brain banks.
Daniel Talmasov +2 more
wiley +1 more source
Effects of Motion in Ultrashort Echo Time Quantitative Susceptibility Mapping for Musculoskeletal Imaging. [PDF]
Sedaghat S +5 more
europepmc +1 more source
The MAC Protocol: We Aren’t There Yet – How Far Do We Have To Go? [PDF]
Gabriel, Henry
core +1 more source
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold +12 more
wiley +1 more source

